Matreya/N-Tricosanoyl ceramide trihexoside/1524/500 µg
Catalog #:1524Scientific Name:N-Tricosanoyl ceramide trihexosideCommon Name:N-C23:0-Ceramide trihexoside; N-Tricosanoyl globotriaosylceramideEmpirical Formula:C59H111NO18SDSView Safety Data SheetData Sheet:View Data SheetFormula Weight:1122Unit:500 µgSolvent:noneSource:semisyntheticPurity:98+%Analytical Methods:TLC, identity confirmed by MSNatural Source:porcine RBCSolubility:DMSO, hot methanol, chloroform/methanol, 2:1Physical Appearance:solidStorage:-20°CDry Ice:NoHazardous:NoLiterature References:1. S. Ashkenazi, and T. Cleary, \"Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their naturalreceptor.” J Clin Microbiol., Vol. 27:6 pp. 1145-1150, 19892. S. Bekri, et al. \"The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: areview of the literature\" Cardiovasc Hematol Agents Med Chem, Vol. 4:4 pp. 289–297, 20063. J. Groener, et al. \"HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma” ClinChem., Vol. 53:4 pp. 742-747, 20074. K. Mills, A. Johnson, B. Winchester, \"Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabrydisease by tandem mass spectrometry” FEBS Lett., Vol. 27 pp. 171-176, 20025. C. Menge, et al. \"Globotriaosylceramide (Gb(3)/CD77) is synthesized and surface expressed by bovine lymphocytes upon activation in vitro” VetImmunol Immunopathol., Vol. 83 pp.19-36, 2001